BREAKWATER safety lead-in (SLI): Encorafenib (E) plus cetuximab (C) plus chemotherapy for BRAFV600E metastatic colorectal cancer (mCRC).
Scott Kopetz, Takayuki Yoshino,Tae Won Kim,Rona Yaeger,Jayesh Desai,Harpreet Singh Wasan,Eric Van Cutsem,Fortunato Ciardiello,Tim Maughan,Cathy Eng,Jeanne Tie,Elena Elez,Sara Lonardi, Xiaosong Zhang, Chin-Hee Chung,Tiziana Usari, Tim Nicholz, Danielle A. Murphy,Josep Tabernero ANNALS OF ONCOLOGY（2023）
AI 理解论文
溯源树
样例
